Aesthetics sector finds an unlikely tailwind in weight-loss drug boom
The rapid adoption of GLP-1 weight-loss drugs is reshaping demand across medical aesthetics. The Botox maker reported a business boost tied to what clinicians and patients call "Ozempic face," the colloquial term for facial…